Gene · 2215
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type I interferon-dependent IFIT3 signaling is critical for viral clearance in airway neutrophils. | Res Sq | 2023 | 36993474 | PubTator, text mining | PubMed |
| The Association of the Polymorphisms in the FUT8-Related Locus with the Plasma Glycosylation in Post-Traumatic Stress Disorder. | Int J Mol Sci | 2023 | 36982780 | PubTator, text mining | PubMed |
| Mycobacterial Heat Shock Proteins in Sarcoidosis and Tuberculosis. | Int J Mol Sci | 2023 | 36982159 | PubTator, text mining | PubMed |
| An integrated single-cell transcriptomic dataset for non-small cell lung cancer. | Sci Data | 2023 | 36973297 | PubTator, text mining | PubMed |
| Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19. | J Clin Immunol | 2023 | 36943669 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma. | Chin Med J (Engl) | 2023 | 36939254 | PubTator, text mining | PubMed |
| The transient receptor potential channels in rheumatoid arthritis: Need to pay more attention. | Front Immunol | 2023 | 36926330 | PubTator, text mining | PubMed |
| Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination. | Cell Rep Med | 2023 | 36921600 | PubTator, text mining | PubMed |
| Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients. | Drug Metab Pers Ther | 2023 | 36919284 | PubTator, text mining | PubMed |
| Case report: Immune profiling links neutrophil and plasmablast dysregulation to microvascular damage in post-COVID-19 Multisystem Inflammatory Syndrome in Adults (MIS-A). | Front Immunol | 2023 | 36911724 | PubTator, text mining | PubMed |
| Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses. | Mol Ther Oncolytics | 2023 | 36911070 | PubTator, text mining | PubMed |
| Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. | NPJ Vaccines | 2023 | 36890168 | PubTator, text mining | PubMed |
| Development of a TMErisk model based on immune infiltration in tumour microenvironment to predict prognosis of immune checkpoint inhibitor treatment in hepatocellular carcinoma. | Brief Bioinform | 2023 | 36882021 | PubTator, text mining | PubMed |
| Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study. | Clin Transl Gastroenterol | 2023 | 36881820 | PubTator, text mining | PubMed |
| Porcine extraintestinal pathogenic Escherichia coli delivers two serine protease autotransporters coordinately optimizing the bloodstream infection. | Front Cell Infect Microbiol | 2023 | 36875517 | PubTator, text mining | PubMed |
| High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions. | MAbs | 2023 | 36859773 | PubTator, text mining | PubMed |
| Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test. | Viruses | 2023 | 36851633 | PubTator, text mining | PubMed |
| Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. | Vaccines (Basel) | 2023 | 36851285 | PubTator, text mining | PubMed |
| Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. | Front Immunol | 2023 | 36845139 | PubTator, text mining | PubMed |
| Modulation of Beta-Amyloid-Activated Primary Human Neutrophils by Dietary Phenols from Virgin Olive Oil. | Nutrients | 2023 | 36839300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2215/papers?page=17